Source: Annual Congress 2004 - Clinical and behavioural consequences of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Ilonidis, G. Anogianakis, A. Anogeianaki, I. Giavazis, E. Theofilogiannakos, P. Glouftsios, P. Tsekoura (Thessaloniki, Greece). D-dimers in patients with chronic obstructive pulmonary disease with or without secondary secondary erythrocytosis. Eur Respir J 2004; 24: Suppl. 48, 210

Member's Comments

No comment yet.

Related content which might interest you: Plasma fibrinogen in patients with chronic obstructive pulmonary disease (COPD) with or without secondary erythrocytosis Source: Eur Respir J 2005; 26: Suppl. 49, 586s Year: 2005 Pneumothorax secondary to chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Secondary pulmonary hypertension in chronic obstructive pulmonary disease and systemic lupus erythematosus- pathophysiology and treatment Source: Eur Respir J 2004; 24: Suppl. 48, 59s Year: 2004 Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension Source: Annual Congress 2010 - COPD: management Year: 2010 Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 60s Year: 2006 Prevalence of anemia of chronic disease in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Erythropoietin in chronic obstructive pulmonary disease patients without anemia Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 IL-8 in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 364s Year: 2001 The impact of anemia on patients with chronic obstructive pulmonary disease in the community Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care Year: 2012 Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005 An early prediction of intravascular microthromb formation for patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Phenotype of patients with severe pulmonary hypertension secondary to chronic obstructive pulmonary disease: A multicentre study. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Pulmonary hypertension associated with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006 Platelet characteristics of patients with chronic obstructive pulmonary disease (COPD) accompanied with lung hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 226s Year: 2007 A study of hematologic disorders in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002 Anemia in chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD comorbidities I Year: 2012